Search Within

Dmitriy Zamarin

  1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (17)
  3. Guidelines (2)
  4. Book Section (1)
Groups
  1. Department of Medicine (46)
  2. GDMT, Medicine (46)
  3. Gynecologic Medicine Service (46)
  4. Gynecology Disease Management Team (46)
  5. Melanoma and Immunotherapeutics Service (46)
  6. Solid Tumor Oncology Division (46)

More Groups

People
  1. Jedd Wolchok (34)
  2. Taha Merghoub (33)
  3. Jacob Ricca (12)
  4. Rikke Holmgaard (12)
  5. Mathieu Gigoux (8)
  6. Cailian Liu (7)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2021 (3)
  4. 2020 (7)
  5. 2019 (3)
  6. 2018 (5)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (10)
  2. Gynecologic Oncology (4)
  3. Cancer Immunology Research (3)
  4. Cell (3)
  5. JCO Precision Oncology (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. Biomed Central Ltd (10)
  2. Elsevier Inc. (6)
  3. American Association for Cancer Research (5)
  4. Cell Press (5)
  5. Nature Publishing Group (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer immunology
    Book Section

    Hobbs, G.; Lesokhin, A. M.; Zamarin, D.; Wolchok, J. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
    Journal Article

    Zamarin, D.; Holmgaard, R. B.; Subudhi, S. K.; Park, J. S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
    Meeting Abstract

    Zamarin, D.; Holmgaard, R.; Subudhi, S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase and T-cell based anti-tumor immunotherapies targeting immune checkpoints
    Meeting Abstract

    Holmgaard, R.; Zamarin, D.; Munn, D.; Wolchok, J.; Allison, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save